...
首页> 外文期刊>Iranian Journal of Microbiology >Study on imipenem resistance and prevalence of blaVIM1 and blaVIM2 metallo-beta lactamases among clinical isolates of Pseudomonas aeruginosa from Mashhad, Northeast of Iran
【24h】

Study on imipenem resistance and prevalence of blaVIM1 and blaVIM2 metallo-beta lactamases among clinical isolates of Pseudomonas aeruginosa from Mashhad, Northeast of Iran

机译:伊朗东北部马什哈德的铜绿假单胞菌临床分离株中亚胺培南耐药性和blaVIM1和blaVIM2金属-β内酰胺酶患病率的研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background and Objectives: The main cause of serious nosocomial infections is a Gram-negative pathogen known as Pseudomonas aeruginosa (P. aeruginosa). Carbapenems are widely used as an appropriate treatment for these infections, however resistance to these agents has been observed and is increasing. Metallo beta-lactamase (MBLs) enzyme is one of the main causes of resistance to carbapenem. In the current study the frequency and production of VIM1 and VIM2 by imipenem-resistant P. aeruginosa isolates of patients hospitalized in Imam Reza hospital were evaluated.Materials and Methods: In this study, 131 clinical samples were collected from patients hospitalized in Imam Reza hospital in Mashhad during a 15-month period from May 2011 to November 2012. After verification of P. aeruginosa isolates, antibiotic resistance patterns of isolates were determined for 14 antibiotics by Kirby-Bauer standard disk diffusion according to the CLSI guidelines. Combined-disk test was used for phenotypic determination of MBLs-producing isolates and after DNA extraction, genotypic determination of VIM1 and VIM2 metallo beta-lactamase genes was carried out using Multiplex- PCR.Results: Of 63 imipenem-resistant isolates (48.5%), 56 (88.8%) were MBL-producing in phenotypic assessments. Also amongst imipenem-resistant isolates, the frequency of VIM1 and VIM2 genes were 58.7 and 3.17%, respectively.Conclusion: The results of the current study along with the results of the other conducted studies in Iran in recent years demonstrate that the average resistance to imipenem in P. aeruginosa isolates was 51.3% which has increased in comparison with the results in 2006 (32.9%). It was also determined that the frequency of VIM1 gene was more than VIM2 gene. In phenotypic assessment by using CD method, 49.6% of isolates were determined as MBLs-producing. The sensitivity and specificity of this method were verified in comparison with the results of PCR test.
机译:背景与目的:导致严重医院感染的主要原因是革兰氏阴性病原体,称为铜绿假单胞菌(P. aeruginosa)。碳青霉烯类被广泛用作这些感染的合适治疗方法,但是已观察到对这些药剂的耐药性并正在增加。金属β-内酰胺酶(MBLs)酶是对碳青霉烯类耐药的主要原因之一。在本研究中,评估了在Imam Reza医院住院的患者对亚胺培南耐药的铜绿假单胞菌分离株VIM1和VIM2的频率和产生。材料和方法:在本研究中,从Imam Reza医院住院的患者中收集了131份临床样品。在2011年5月至2012年11月的15个月内,该药物在Mashhad进行了检疫。在验证了铜绿假单胞菌的分离物后,根据CLSI指南,通过Kirby-Bauer标准圆盘扩散法确定了14种抗生素的分离物的耐药性模式。联合圆盘检测法用于产生MBLs的分离株的表型测定,DNA提取后,通过多重PCR对VIM1和VIM2金属β-内酰胺酶基因进行基因型测定。结果:63株耐亚胺培南的分离株(48.5%)在表型评估中,有56(88.8%)个产生MBL。在亚胺培南耐药菌株中,VIM1和VIM2基因的频率分别为58.7和3.17%。结论:本研究的结果以及近年来在伊朗进行的其他研究结果表明,对IMP的平均耐药性铜绿假单胞菌分离物中的亚胺培南为51.3%,与2006年的结果(32.9%)相比有所增加。还确定了VIM1基因的频率大于VIM2基因。在通过CD法进行的表型评估中,有49.6%的分离物被确定为产生MBL。与PCR试验结果比较,验证了该方法的敏感性和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号